Effect of inhibitor of tumor necrosis factor-α and oxatomide on immune mediated otitis media

Laryngoscope

Volumn 116, Issue 9, 2006, Pages 1642-1646

  Park, Yong Soo ^a   Auo, Hyeon Jin ^b   Jeon, Eun Ju ^a,c   Chang, Ki Hong ^a   Lee, Seung Kyun ^a   Lee, Dong Hee ^a  

^a The Catholic University of Korea   (South Korea)

^b Yeson Voice Center   (South Korea)

^c Our Lady Mercy Hospital   (South Korea)

Author keywords

Otitis media with effusion; Oxatomide; Tumor necrosis factor

Indexed keywords

LEUKOTRIENE; OXATOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MIDDLE EAR EFFUSION; MIDDLE EAR MUCOSA; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RAT;

ANIMALS; CAPILLARY PERMEABILITY; EAR, MIDDLE; EVANS BLUE; HEMOCYANIN; IMMUNOENZYME TECHNIQUES; OTITIS MEDIA WITH EFFUSION; PHOTOMICROGRAPHY; PIPERAZINES; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748554172     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000232545.08028.b3     Document Type: Article

References (17)

1. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-169.
2. Lesslauer W, Tabuchi H, Gentz R, et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991;21:2883-2886.
3. Ulich TR, Yi ES, Yin S, et al. Intratracheal administration of endotoxin and cytokines. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin Immunol Immunopathol 1994;72:137-140.
4. Maxwell K, Leonard G, Kreutzer DL. Cytokine expression in otitis media with effusion. Arch Otolaryngol Head Neck Surg 1997;123:984-988.
5. Tanaka T, Kurono Y, Kawauchi H, Mogi G. Effect of oxatomide on otitis media with effusion-an experimental study. Acta Otolaryngol 1995;115:532-538.
6. Harris JP, Ryan AF. Effect of a middle ear immune response on inner ear antibody levels. Ann Otol Rhinol Laryngol 1985;94:202-206.
7. Ryan AF, Catanzaro A, Wasserman SI, Harris JP. Secondary immune response in the middle ear: immunological, morphological, and physiological observations. Ann Otol Rhinol Laryngol 1986;95:242-249.
8. Takahashi M, Kanai N, Watonabe A, et al. Lymphocyte subsets in immune-mediated otitis media with effusion. Eur Arch Otorhinolaryngol 1992;249:24-27.
9. Bikhazi P, Ryan AF. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope 1995;105:629-634.
10. Ball SS, Prazma J, Dean Dais CG, et al. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann Otol Rhinol Laryngol 1997;106:633-639.
11. Jeon E, Park YS, Choi YC, Lee JH. Effect of inhibitor of TNF-α on lipopolysaccharide-induced otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:917-921.
12. Catanzaro A, Ryan AF, Robb JA. Immunologically mediated and nonspecific inflammatory responses in the middle ear. Clin Immunol Immunopathol 1982;24:361-376.
13. Harris JR, Markl J. Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 1999;30:597-623.
14. Suzuki M, Kawauchi H, Mogi G. Immune-mediated otitis media with effusion. Am J Otolaryngol 1988;9:199-209.
15. Ophir D, Hahn T, Schattner A, et al. Tumor necrosis factor in middle ear effusion. Arch Otolaryngol Head Neck Surg 1988;114:1256-1258.
16. Edamitsu S, Matsukawa A, Ohkawara S, et al. Role of TNF-α, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS- induced pleurisy. Clin Immunol Immunopathol 1995;75:68-74.
17. 2) from rat mast cells and guinea-pig lung. Agents Actions 1987;21:32-37.